Under Vioxx Fire, Merck Faces Fosamax Claims Too

Law360, New York (July 11, 2006, 12:00 AM EDT) -- With trials over the potential side effects of Merck & Co.’s former blockbuster Vioxx underway, the pharmaceutical giant may soon be headed to court on charges related to its second-biggest seller, Fosamax, in a slew of class action suits that allege the osteoporosis drug could lead to jaw deterioration.

Since April, plaintiffs firm Levin Papantonio Thomas Mitchell Echsner & Proctor PA has filed more than two dozen lawsuits in Florida federal court over the drug.

Timothy O’Brien, lead attorney in the Florida cases, told the L.A....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.